Liothyronine supply update for prescribers

Manufacturers have notified intermittent supply constraints affecting some strengths of liothyronine over the coming weeks. Most patients should be unaffected, but prescribers should be aware of the position before making changes.

The Society will share further detail with members by email and at the next regional meeting. Updates will also be posted on this page as they are confirmed, so members working across different units see the same information at the same time.

What this means for members

• Review how current supply guidance affects your unit and share questions with the committee.
• Raise discussion points through your Endocrine Network or regional representative.
• Watch the events calendar — related sessions will be added where there is demand.

“Our aim is simple: every endocrine team in the North West working from the same, current information.”

If you have feedback or would like to contribute to this work, contact the Society office and we will connect you with the relevant committee lead.